ALLO - Allogene Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

ALLO is currently covered by 14 analysts with an average potential upside of $13.51 (95.76%) backed by displayed 55 price targets and 98 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 35.09% with an average time for these price targets to be met of 76.53 days.

Highest price target for ALLO is 25, Lowest price target is 5, average price target is 15.

Most recent stock forecast was given by MARK BREIDENBACH from OPPENHEIMER on 03-Aug-2023. First documented stock forecast 15-Mar-2019.

Currently, out of the existing stock ratings of ALLO - 8 which are a Hold (16.33%), 41 which are a Buy (83.67%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

28

$24.61 (725.96%)

28

1 months 25 days ago

2/9 (22.22%)

$17.97 (165.58%)

194

Buy

18

$14.61 (430.97%)

20

2 months 16 days ago

2/9 (22.22%)

$10.36 (97.27%)

93

Buy

35

$31.61 (932.45%)

55

3 months 12 days ago

1/3 (33.33%)

$24.87 (286.09%)

192

Buy

15

$11.61 (342.48%)

19

3 months 23 days ago

2/7 (28.57%)

$11.18 (121.55%)

106

Buy

32

6 months 27 days ago

3/5 (60%)

$8.07 (50.72%)

43

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ALLO (Allogene Therapeutics) average time for price targets to be met?

On average it took 76.53 days on average for the stock forecasts to be realized with a an average price target met ratio 35.09

Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?

Tyler Van Buren works at TD COWEN and has 0 price targets and 0 ratings on ALLO

Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?

Biren Amin with highest potential upside - $49.61

Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?

Dane Leone with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart